Clinical trial

Observational Study to Evaluate the Safety of Levemir® in Diabetes

NCT00659295

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record insulin detemir Normalized identity: insulin detemirView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2004-06-01

PhaseN/A

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

insulin detemirDRUG · verified · RxNorm: insulin detemir

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

SeoulSouth Korea1 PragueCzechia1 BrusselsBelgium1 IstanbulTurkey (Türkiye)1 DublinIreland1 RomeItaly1 Kfar SabaIsrael1 MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00659295 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.